Response to: Ruxolitinib withdrawal due to the COVID-19

被引:0
作者
Barbui, Tiziano [1 ]
Carobbio, Alessandra [1 ]
机构
[1] Papa Giovanni XXIII Hosp, FROM Res Fdn, Bergamo, Italy
关键词
D O I
10.1038/s41375-021-01187-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1219 / 1219
页数:1
相关论文
共 2 条
  • [1] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
    Barbui, Tiziano
    Vannucchi, Alessandro Maria
    Alvarez-Larran, Alberto
    Iurlo, Alessandra
    Masciulli, Arianna
    Carobbio, Alessandra
    Ghirardi, Arianna
    Ferrari, Alberto
    Rossi, Giuseppe
    Elli, Elena
    Andrade-Campos, Marcio Miguel
    Kabat, Mercedes Gasior
    Kiladjian, Jean-Jaques
    Palandri, Francesca
    Benevolo, Giulia
    Garcia-Gutierrez, Valentin
    Fox, Maria Laura
    Foncillas, Maria Angeles
    Morcillo, Carmen Montoya
    Rumi, Elisa
    Osorio, Santiago
    Papadopoulos, Petros
    Bonifacio, Massimiliano
    Cervantes, Keina Susana Quiroz
    Serrano, Miguel Sagues
    Carreno-Tarragona, Gonzalo
    Sobas, Marta Anna
    Lunghi, Francesca
    Patriarca, Andrea
    Elorza, Begona Navas
    Angona, Anna
    Mazo, Elena Magro
    Koschmieder, Steffen
    Ruggeri, Marco
    Cuevas, Beatriz
    Hernandez-Boluda, Juan Carlos
    Abadia, Emma Lopez
    Cirici, Blanca Xicoy
    Guglielmelli, Paola
    Garrote, Marta
    Cattaneo, Daniele
    Daffini, Rosa
    Cavalca, Fabrizio
    Bellosillo, Beatriz
    Benajiba, Lina
    Curto-Garcia, Natalia
    Bellini, Marta
    Betti, Silvia
    De Stefano, Valerio
    Harrison, Claire
    [J]. LEUKEMIA, 2021, 35 (02) : 485 - 493
  • [2] Mediation analysis in epidemiology: methods, interpretation and bias
    Richiardi, Lorenzo
    Bellocco, Rino
    Zugna, Daniela
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2013, 42 (05) : 1511 - 1519